| Catalog number: | bs-6649R-Biotin |
|---|---|
| Price: | 465 € |
| Supplier: | Bluegen antibodies |
| Product name: | ADORA1 Antibody, Biotin Conjugated |
| Quantity: | 200ug (50ug, 100ug available) |
| Other quantities: | 0.1ml 333€ |
| Related search: |
| Long name: | Biotin Conjugated, ADORA1 Polyclonal Antibody |
|---|---|
| Category: | Conjugated Primary Antibodies |
| Conjugation: | Biotinylated |
| Host Organism: | Rabbit (Oryctolagus cuniculus) |
| Target Antigen: | ADORA1 |
| Specificity: | This is a highly specific antibody against ADORA1 |
| Modification: | Unmodified |
| Modification site: | None |
| Clonality: | Polyclonal |
| Clone: | Polyclonal antibody |
| Concentration: | 1ug per 1ul |
| Immunogen_range: | 202-238/326 |
| Subcellular location: | Cytoplasm |
| Source: | KLH conjugated synthetic peptide derived from human Adenosine A1 Receptor |
| Gene ID number: | 134 |
| Swiss Prot: | P30542 |
| Tested applications: | IHC-P, WB |
| Recommended dilutions: | IHC-P(1:100-500), WB(1:100-1000) |
| Crossreactivity: | Mouse, Rat, Human |
| Crossreactive species details: | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Antigen background: | Activation of Adenosine A3-R inhibits the induction of TNF?and blocks the endotoxin CD14 receptor signal transduction pathway, Adenosine A1-R mediates ureagenesis in a partially calcium-dependent manner, Adenosine A2A-R, Adenosine A2B-R and Adenosine A3-R, Adenosine is known to mediate coronary vasodilation via Adenosine A2A-R, Collagen synthesis and total protein synthesis are inhibited in certain cells by Adenosine, The Adenosine receptors, acting via the A2B receptors, and the inhibition of protein synthesis, are integral membrane proteins that are members of the G protein-coupled receptor family, including Adenosine A1-R, including the synthesis of urea, the anti-inflammatory response, Adenosine is involved in a variety of processes |
| Purification method: | This antibody was purified via Protein A |
| Storage conditions: | 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA |
| Synonyms: | RDC7 |
| Properties: | Avidin and Streptavidin bind to the small biotin and are couple to HRP or AP for ELISA, Biotin conjugates can be detected by horseradish peroxidase, To break the streptavidin Biotin bond we suggest to use a 6 molar guanidine HCl solution with acidity of pH 1, alkaline phosphatase substrates or anti biotin conjugated antibodies, 6, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24° |
| Gene target: | ADORA1 Conjugated |
| Short name: | Conjugated, ADORA1 Antibody |
| Technique: | antibodies against human proteins, antibodies for, antibody Conjugates, Antibody |
| Label: | Biotin |
| Alternative name: | biotinilated coupled, adenosine A1 receptor (Antibody to) |
| Alternative technique: | antibodies |
| Alternative to gene target: | ADORA1 and IDBG-105921 and ENSG00000163485 and 134, ADORA1 and IDBG-628574 and ENSBTAG00000011461 and 282133, Adora1 and IDBG-193467 and ENSMUSG00000042429 and 11539, GABAergic and biological process this GO :0032244 and positive regulation of nucleoside transport and biological process this GO :0032279 and asymmetric synapse and cellular component this GO :0032795 and heterotrimeric G-protein binding and molecular function this GO :0032900 and negative regulation of neurotrophin production and biological process this GO :0035307 and positive regulation of protein dephosphorylation and biological process this GO :0035814 and negative regulation of renal sodium excretion and biological process this GO :0042321 and negative regulation of circadian sleep/wake cycle, Plasma membranes, RDC7, glutamatergic and biological process this GO :0055117 and regulation of cardiac muscle contraction and biological process this GO :0055118 and negative regulation of cardiac muscle contraction and biological process this GO :0060079 and regulation of excitatory postsynaptic membrane potential and biological process this GO :0060087 and relaxation of vascular smooth muscle and biological process this GO :0070256 and negative regulation of mucus secretion and biological process this GO :0097190 and apoptotic signaling pathway and biological process, non-REM sleep and biological process this GO :0042734 and presynaptic membrane and cellular component this GO :0043025 and neuronal cell body and cellular component this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043195 and terminal bouton and cellular component this GO :0043268 and positive regulation of potassium ion transport and biological process this GO :0044297 and cell body and cellular component this GO :0045211 and postsynaptic membrane and cellular component this GO :0045741 and positive regulation of epidermal growth factor-activated receptor activity and biological process this GO :0045776 and negative regulation of blood pressure and biological process this GO :0045777 and positive regulation of blood pressure and biological process this GO :0045822 and negative regulation of heart contraction and biological process this GO :0045908 and negative regulation of vasodilation and biological process this GO :0046888 and negative regulation of hormone secretion and biological process this GO :0046982 and protein heterodimerization activity and molecular function this GO :0048167 and regulation of synaptic plasticity and biological process this GO :0048786 and presynaptic active zone and cellular component this GO :0050728 and negative regulation of inflammatory response and biological process this GO :0050890 and cognition and biological process this GO :0050965 and detection of temperature stimulus involved in sensory perception of pain and biological process this GO :0050995 and negative regulation of lipid catabolic process and biological process this GO :0051930 and regulation of sensory perception of pain and biological process this GO :0051967 and negative regulation of synaptic transmission, protein heterodimerization activity, sleep and biological process this GO :0042323 and negative regulation of circadian sleep/wake cycle, this GO :0000186 and activation of MAPKK activity and biological process this GO :0001609 and G-protein coupled adenosine receptor activity and molecular function this GO :0001659 and temperature homeostasis and biological process this GO :0001664 and G-protein coupled receptor binding and molecular function this GO :0001666 and response to hypoxia and biological process this GO :0001883 and purine nucleoside binding and molecular function this GO :0001973 and adenosine receptor signaling pathway and biological process this GO :0002087 and regulation of respiratory gaseous exchange by neurological system process and biological process this GO :0002674 and negative regulation of acute inflammatory response and biological process this GO :0002686 and negative regulation of leukocyte migration and biological process this GO :0002793 and positive regulation of peptide secretion and biological process this GO :0003093 and regulation of glomerular filtration and biological process this GO :0004629 and phospholipase C activity and molecular function this GO :0004930 and G-protein coupled receptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005783 and endoplasmic reticulum and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006612 and protein targeting to membrane and biological process this GO :0006909 and pha this GO cytosis and biological process this GO :0006954 and inflammatory response and biological process this GO :0007165 and signal transduction and biological process this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0007193 and adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway and biological process this GO :0007267 and cell-cell signaling and biological process this GO :0007399 and nervous system development and biological process this GO :0008285 and negative regulation of cell proliferation and biological process this GO :0012505 and endomembrane system and cellular component this GO :0014050 and negative regulation of glutamate secretion and biological process this GO :0014069 and postsynaptic density and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0016042 and lipid catabolic process and biological process this GO :0016323 and basolateral plasma membrane and cellular component this GO :0030425 and dendrite and cellular component this GO :0030673 and axolemma and cellular component this GO :0031683 and G-protein beta/gamma-subunit complex binding and molecular function this GO :0032229 and negative regulation of synaptic transmission, this GO :0001609 : G-protein coupled adenosine receptor activity, this GO :0001609 : G-protein coupled adenosine receptor activity and also this GO :0001664 : G-protein coupled receptor binding and also this GO :0001883 : purine nucleoside binding and also this GO :0004629 : phospholipase C activity and also this GO :0004930 : G-protein coupled receptor activity and also this GO :0005515 : protein binding and also this GO :0031683 : G-protein beta/gamma-subunit complex binding and also this GO :0032795 : heterotrimeric G-protein binding and also this GO :0046982 : protein heterodimerization activity, this GO :0001664 : G-protein coupled receptor binding, this GO :0001883 : purine nucleoside binding, this GO :0004629 : phospholipase C activity, this GO :0004930 : G-protein coupled receptor activity, this GO :0005515 : protein binding, this GO :0031683 : G-protein beta/gamma-subunit complex binding, this GO :0032795 : heterotrimeric G-protein binding, this GO :0046982 : protein heterodimerization activity, 787449, adenosine A1 receptor |
| Identity: | 262 |
| Gene: | ADORA1 | More about : ADORA1 |
| Long gene name: | adenosine A1 receptor |
| Locus: | 1q32, 1 |
| Discovery year: | 1991-03-11 |
| GenBank acession: | BC026340 |
| Entrez gene record: | 134 |
| Pubmed identfication: | 1662665 2541503 |
| RefSeq identity: | NM_000674 |
| Classification: | Adenosine receptors |
| Havana BLAST/BLAT: | OTTHUMG00000042125 |
| bs-4235R-Biotin | ADORA1 Antibody, Biotin Conjugated | 0.1ml | 333 € | Bioss Primary Conjugated Antibodies | human |
| bs-6649R-Biotin | ADORA1 Antibody, Biotin Conjugated | 0.1ml | 333 € | Bioss Primary Conjugated Antibodies | human |
| bs-4235R-Cy3 | ADORA1 Antibody, Cy3 Conjugated | 0.1ml | 350 € | Bioss Primary Conjugated Antibodies | human |
| bs-6649R-Cy3 | ADORA1 Antibody, Cy3 Conjugated | 0.1ml | 350 € | Bioss Primary Conjugated Antibodies | human |
| bs-4235R-Cy5 | ADORA1 Antibody, Cy5 Conjugated | 0.1ml | 350 € | Bioss Primary Conjugated Antibodies | human |
| bs-6649R-Cy5 | ADORA1 Antibody, Cy5 Conjugated | 0.1ml | 350 € | Bioss Primary Conjugated Antibodies | human |
| bs-4235R-Cy5.5 | ADORA1 Antibody, Cy5.5 Conjugated | 0.1ml | 350 € | Bioss Primary Conjugated Antibodies | human |
| bs-6649R-Cy5.5 | ADORA1 Antibody, Cy5.5 Conjugated | 0.1ml | 350 € | Bioss Primary Conjugated Antibodies | human |
| bs-4235R-Cy7 | ADORA1 Antibody, Cy7 Conjugated | 0.1ml | 350 € | Bioss Primary Conjugated Antibodies | human |
| bs-6649R-Cy7 | ADORA1 Antibody, Cy7 Conjugated | 0.1ml | 350 € | Bioss Primary Conjugated Antibodies | human |
| bs-4235R-FITC | ADORA1 Antibody, FITC Conjugated | 0.1ml | 333 € | Bioss Primary Conjugated Antibodies | human |
| bs-6649R-FITC | ADORA1 Antibody, FITC Conjugated | 0.1ml | 333 € | Bioss Primary Conjugated Antibodies | human |
| bs-4235R-HRP | ADORA1 Antibody, HRP Conjugated | 0.1ml | 350 € | Bioss Primary Conjugated Antibodies | human |
| bs-6649R-HRP | ADORA1 Antibody, HRP Conjugated | 0.1ml | 350 € | Bioss Primary Conjugated Antibodies | human |
| bs-6649R-PE | ADORA1 Antibody, PE Conjugated | 0.1ml | 368 € | Bioss Primary Conjugated Antibodies | human |
| GWB-MV795C | ADORA1 antibody | 1 vial | 521 € | genways | human |
| GWB-MV796D | ADORA1 antibody | 1 vial | 521 € | genways | human |
| bs-4235R-A350 | ADORA1 Antibody, ALEXA FLUOR 350 | 100ul | 332 € | Bioss Primary Conjugated Antibodies. | human |
| bs-6649R-A350 | ADORA1 Antibody, ALEXA FLUOR 350 | 100ul | 332 € | Bioss Primary Conjugated Antibodies. | human |
| bs-4235R-A488 | ADORA1 Antibody, ALEXA FLUOR 488 | 100ul | 332 € | Bioss Primary Conjugated Antibodies. | human |
| bs-6649R-A488 | ADORA1 Antibody, ALEXA FLUOR 488 | 100ul | 332 € | Bioss Primary Conjugated Antibodies. | human |
| bs-4235R-A555 | ADORA1 Antibody, ALEXA FLUOR 555 | 100ul | 332 € | Bioss Primary Conjugated Antibodies. | human |
| bs-6649R-A555 | ADORA1 Antibody, ALEXA FLUOR 555 | 100ul | 332 € | Bioss Primary Conjugated Antibodies. | human |
| bs-4235R-A594 | ADORA1 Antibody, ALEXA FLUOR 594 | 100ul | 332 € | Bioss Primary Conjugated Antibodies. | human |
| bs-6649R-A594 | ADORA1 Antibody, ALEXA FLUOR 594 | 100ul | 332 € | Bioss Primary Conjugated Antibodies. | human |
| bs-4235R-A647 | ADORA1 Antibody, ALEXA FLUOR 647 | 100ul | 332 € | Bioss Primary Conjugated Antibodies. | human |
| bs-6649R-A647 | ADORA1 Antibody, ALEXA FLUOR 647 | 100ul | 332 € | Bioss Primary Conjugated Antibodies. | human |
| bs-4235R | ADORA1 Antibody | 0.1ml | 263 € | Bioss Primary Unconjugated Antibodies | human |
| bs-6649R | ADORA1 Antibody | 0.1ml | 263 € | Bioss Primary Unconjugated Antibodies | human |
| A04A0095 | anti-ADORA1 Antibody | 200ug (50ug, 100ug available) | 465 € | Bluegen antibodies | human |